Filing Flows › Comparisons › ENTA vs ABEO
Enanta Pharmaceuticals vs Abeona Therapeutics: ENTA and ABEO compared
Enanta Pharmaceuticals is the larger company: $14.4M of revenue in its latest quarter (Q3 FY26) against $13.5M for Abeona Therapeutics (Q3 2026). Abeona Therapeutics is more profitable, with an operating margin of -96.4% against -120.0%.
Where the money goes: ENTA and ABEO
Enanta Pharmaceuticals (ENTA) · Q3 FY26
Enanta Pharmaceuticals, Q3 FY26: revenue $14.4M (-22% year over year), operating margin -120.0%, net loss $19.5M, operating cash flow −$10.0M. The chart follows the revenue to costs, profit and cash.
Abeona Therapeutics (ABEO) · Q3 2026
Abeona Therapeutics, Q3 2026: revenue $13.5M, operating margin -96.4%, net loss $4.8M, operating cash flow −$8.3M. The chart follows the revenue to costs, profit and cash.
| Enanta Pharmaceuticals (ENTA) | Abeona Therapeutics (ABEO) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q3 2026 |
| Revenue | $14.4M | $13.5M |
| Revenue growth, Y/Y | -22% | — |
| Operating margin | -120.0% | -96.4% |
| Net earnings | −$19.5M | −$4.8M |
| Net margin | -135.8% | -35.6% |
| Operating cash flow | −$10.0M | −$8.3M |
Questions
Which is bigger, Enanta Pharmaceuticals or Abeona Therapeutics?
Enanta Pharmaceuticals is the larger company: $14.4M of revenue in its latest quarter (Q3 FY26) against $13.5M for Abeona Therapeutics (Q3 2026).
Is Enanta Pharmaceuticals or Abeona Therapeutics growing faster?
Abeona Therapeutics is more profitable, with an operating margin of -96.4% against -120.0%.
More: Enanta Pharmaceuticals earnings · how Enanta Pharmaceuticals makes money · Abeona Therapeutics earnings · how Abeona Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.